Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma

• Published in: Head & neck Vol. 18; no. 6; pp. 512 - 521
• Main Authors: Davidson, Bruce J., Lydiatt, William M., Abate, Megan P., Schantz, Stimson P., Chaganti, R.S.K.
• Format: Journal Article
• Language: English
• Published: New York Wiley Subscription Services, Inc., A Wiley Company 01.11.1996; John Wiley & Sons
• Subjects: Aged; Biological and medical sciences; Blotting, Northern; Blotting, Southern; Carcinoma, Squamous Cell - etiology; Carcinoma, Squamous Cell - genetics; Carcinoma, Squamous Cell - pathology; Cyclin D1; Cyclins - genetics; Female; Gene Amplification; Gene Expression; Head and Neck Neoplasms - etiology; Head and Neck Neoplasms - genetics; Head and Neck Neoplasms - pathology; Humans; Male; Medical sciences; Middle Aged; Oncogene Proteins - genetics; Otorhinolaryngology. Stomatology; Risk Factors; RNA, Messenger - analysis; Smoking - adverse effects; Tumors; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology; Human; Squamous cell carcinoma; Upper aerodigestive tract; Malignant tumor; Gene expression; Carcinogenesis; Gene amplification; Tobacco; Association; C-Onc gene; Risk factor; Cytogenetics; Head and neck; ENT disease; Protooncogene
• ISSN: 1043-3074; 1097-0347
• DOI: 10.1002/(SICI)1097-0347(199611/12)18:6<512::AID-HED5>3.0.CO;2-5

Background Amplification of the cyclin D1 (CCND1) gene, which encodes a cell cycle regulating protein, has been described in several solid tumors including head and neck squamous cell carcinoma (HNSCC). While correlations between CCND1 amplification and tumor behavior have been suggested, no investigation has focused on risk factor exposure as a potential cause of CCND1 alteration. Methods Southern blotting was used to identify CCND1 amplification in 57 previously untreated HNSCC tumor specimens. Tissue from 27 cases was analyzed for CCND1 mRNA expression by Northern blot analysis. Results In 13/57 (23%) cases, a 2–5 fold amplification of CCND1 was found. CCND1 mRNA expression was higher in amplified than in non‐amplified tumors and supported an association between CCND1 amplification and increased expression of CCND1 mRNA. No correlation was found between CCND1 amplification or CCND1 expression and clinical or pathological parameters. However, analysis of risk factor exposure revealed that patients with greater tobacco exposure were more likely to have tumors with CCND1 amplification (p = .037). Also, tobacco exposure was correlated with CCND1 expression in tumors. Conclusion Tobacco exposure is a well‐known risk factor for HNSCC. CCND1 amplification and alterations in expression may be causally related to tobacco carcinogen exposure and lead to a loss of cell cycle regulation. HEAD & NECK 1996;18:512–521 © 1996 John Wiley & Sons, Inc.